Ekso Bionics Holdings Inc [NASDAQ: EKSO] slipped around -0.05 points on Thursday, while shares priced at $0.40 at the close of the session, down -11.50%.
Compared to the average trading volume of 198.00K shares, EKSO reached a trading volume of 98434458 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Ekso Bionics Holdings Inc [EKSO]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EKSO shares is $2.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EKSO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
SunTrust have made an estimate for Ekso Bionics Holdings Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 14, 2016.
The Average True Range (ATR) for Ekso Bionics Holdings Inc is set at 0.06, with the Price to Sales ratio for EKSO stock in the period of the last 12 months amounting to 0.66. The Price to Book ratio for the last quarter was 0.89, with the Price to Cash per share for the same quarter was set at 0.28.
How has EKSO stock performed recently?
Ekso Bionics Holdings Inc [EKSO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.24. With this latest performance, EKSO shares gained by 0.73% in over the last four-week period, additionally sinking by -48.32% over the last 6 months – not to mention a drop of -71.01% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EKSO stock in for the last two-week period is set at 41.94, with the RSI for the last a single of trading hit 37.51, and the three-weeks RSI is set at 43.65 for Ekso Bionics Holdings Inc [EKSO]. The present Moving Average for the last 50 days of trading for this stock 0.4262, while it was recorded at 0.4313 for the last single week of trading, and 0.7360 for the last 200 days.
Ekso Bionics Holdings Inc [EKSO]: Deeper insight into the fundamentals
Ekso Bionics Holdings Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.77 and a Current Ratio set at 2.35.
Earnings analysis for Ekso Bionics Holdings Inc [EKSO]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EKSO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Ekso Bionics Holdings Inc go to 41.87%.
Insider trade positions for Ekso Bionics Holdings Inc [EKSO]
The top three institutional holders of EKSO stocks are: KENT LAKE CAPITAL LLC with ownership of 0.7 million shares, which is approximately 3.8194%. VANGUARD GROUP INC, holding 0.59 million shares of the stock with an approximate value of $$0.63 million in EKSO stocks shares; and VANGUARD GROUP INC, currently with $$0.32 million in EKSO stock with ownership which is approximately 1.6462%.
